✦ LIBER ✦

MS520 FENOFIBRATE TREATMENT REDUCES THE OCCURRENCE OF RECURRENT CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES

✍ Scribed by Foucher, C.; Le Malicot, K.; Ansquer, J.-C.; Gebski, V.; Keech, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ROLE OF FENOFIBRATE IN THE RISK FACTORS

✍ Ikramova, B.R.; Akbarova, N.M.; Rakhimova, N.M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Pioglitazone reduces risk of recurrent s

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Effects of long-term fenofibrate therapy

✍ Charles A. Reasner 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 51 KB

Effects of fenofibrate on renal function

✍ T. M. E. Davis; R. Ting; J. D. Best; M. W. Donoghoe; P. L. Drury; D. R. Sullivan 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 320 KB

Effects of fenofibrate on cardiovascular

✍ Andrew Tonkin; David Hunt; Merryn Voysey; Antero Kesäniemi; Andrew Hamer; Jonath 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Effects of Fenofibrate Treatment on Card

✍ Scott, R.; O'Brien, R.; Fulcher, G.; Pardy, C.; d'Emden, M.; Tse, D.; Taskinen, 📂 Article 📅 2008 🏛 American Diabetes Association 🌐 English ⚖ 506 KB